Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST 2)

This study has been completed.
Information provided by:
Pfizer Identifier:
First received: February 28, 2007
Last updated: October 24, 2007
Last verified: April 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: February 2004
  Estimated Primary Completion Date: No date given
No publications provided by Pfizer

Publications automatically indexed to this study by Identifier (NCT Number):